14-day Premium Trial Subscription Try For FreeTry Free
$11.19
-0.760 (-6.36%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $10.30 $12.26 Thursday, 2nd May 2024 GHRS stock ended at $11.19. This is 6.36% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 8.94% from a day low at $11.19 to a day high of $12.19.
90 days $6.82 $12.26
52 weeks $5.05 $14.64

Historical GH Research PLC prices

Date Open High Low Close Volume
May 02, 2024 $11.94 $12.19 $11.19 $11.19 71 777
May 01, 2024 $11.11 $12.22 $10.97 $11.95 116 965
Apr 30, 2024 $10.77 $11.26 $10.77 $10.96 60 948
Apr 29, 2024 $10.57 $10.87 $10.57 $10.75 12 665
Apr 26, 2024 $10.47 $10.75 $10.40 $10.51 19 945
Apr 25, 2024 $10.83 $10.83 $10.30 $10.50 32 008
Apr 24, 2024 $11.37 $11.37 $10.85 $11.08 45 263
Apr 23, 2024 $11.87 $12.26 $11.25 $11.30 42 063
Apr 22, 2024 $11.17 $11.93 $10.95 $11.72 67 381
Apr 19, 2024 $11.23 $11.23 $10.92 $11.03 63 385
Apr 18, 2024 $11.13 $11.31 $10.78 $11.19 250 663
Apr 17, 2024 $10.91 $11.03 $10.54 $10.99 77 609
Apr 16, 2024 $11.72 $11.92 $10.97 $10.99 36 521
Apr 15, 2024 $11.25 $11.76 $11.03 $11.72 88 830
Apr 12, 2024 $11.00 $11.19 $10.90 $11.19 166 568
Apr 11, 2024 $11.02 $11.61 $10.92 $11.00 80 549
Apr 10, 2024 $11.03 $11.11 $10.90 $11.05 143 006
Apr 09, 2024 $11.08 $11.16 $10.93 $11.09 23 427
Apr 08, 2024 $11.23 $11.38 $11.05 $11.06 12 831
Apr 05, 2024 $11.05 $11.47 $10.74 $11.14 51 972
Apr 04, 2024 $11.03 $11.48 $10.84 $11.02 123 412
Apr 03, 2024 $11.03 $11.08 $10.81 $10.99 204 539
Apr 02, 2024 $11.16 $11.23 $10.84 $11.04 189 848
Apr 01, 2024 $10.56 $11.23 $10.56 $11.08 210 727
Mar 28, 2024 $10.87 $10.87 $10.59 $10.66 44 423
Click to get the best stock tips daily for free!

About GH Research PLC

GH Research PLC GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1... GHRS Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT